These changes were accompanied by strong inhibition of the upregulation of the expression of the MLL-fusion target genes HOXA9, MEIS1, MEF2C, and PBX3, which are important in leukemia development, cell proliferation, and self-renewal. This evidence concerns the gene HOXA9 and leukemia.